BTO-1

BTO-1 Structure
CAS No.
40647-02-7
Chemical Name:
BTO-1
Synonyms
BTO-1;Polo-like Kinase Inhibitor II, BTO-1;5-Cyano-7-nitro-2-benzothiazolecarboxamide-3-oxide;2-Benzothiazolecarboxamide, 5-cyano-7-nitro-, 3-oxide;Polo-like Kinase Inhibitor II, BTO-1 - CAS 40647-02-7 - Calbiochem
CBNumber:
CB8972299
Molecular Formula:
C9H4N4O4S
Molecular Weight:
264.22
MOL File:
40647-02-7.mol
MSDS File:
SDS
Modify Date:
2023/4/23 13:52:06

BTO-1 Properties

Boiling point 553.0±60.0 °C(Predicted)
Density 1.89±0.1 g/cm3(Predicted)
storage temp. 2-8°C
solubility H2O: <2ML/mL
form solid
pka 14.67±0.30(Predicted)
color tan

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302-H312-H315-H319-H332-H335
Precautionary statements  P261-P280-P305+P351+P338
Hazard Codes  Xn
Risk Statements  20/21/22-36/37/38
Safety Statements  26-36/37
WGK Germany  3

BTO-1 price More Price(3)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) B6311 BTO-1 ≥98% (HPLC), solid 40647-02-7 5MG ₹17731.35 2022-06-14 Buy
Sigma-Aldrich(India) B6311 BTO-1 ≥98% (HPLC), solid 40647-02-7 25MG ₹70827.98 2022-06-14 Buy
Sigma-Aldrich(India) 528283 Polo-like Kinase Inhibitor II, BTO-1 - CAS 40647-02-7 - Calbiochem The Polo-like Kinase Inhibitor II, BTO-1, also referenced under CAS 40647-02-7, controls the biological activity of Polo-like Kinase. This small molec 40647-02-7 2MG ₹9490 2022-06-14 Buy
Product number Packaging Price Buy
B6311 5MG ₹17731.35 Buy
B6311 25MG ₹70827.98 Buy
528283 2MG ₹9490 Buy

BTO-1 Chemical Properties,Uses,Production

General Description

A cell-permeable benzothiazolo-N-oxide compound that targets the ATP-binding pocket of polo-like kinase and is shown to inhibit Plk1 kinase activity in cell-free kinase assays (IC50 = 8.0 μM) and suppress the phosphorylation of cellular Plk1 substrate Cdc25C in rat kangaroo kidney-derived PTK cells (75% inhibition at 6.3 μM). BTO-1 treatment of cultured cells results in mitosis defects consistent with loss-of-Plk1 phenotypes seen in Plk1 RNAi-treated U20S cells, including the appearance of monopolar spindles and the reduction of γ-tubulin at the centrosomes. Plk1 inhibition by BTO-1 in HeLa cells results in a blockage of Rho and Rho-GEF recruitment, which is essential for the assembly of a functional contractile ring.

Biochem/physiol Actions

BTO-1 is a polo-like kinase (Plk) inhibitor.

BTO-1 Preparation Products And Raw materials

Raw materials

Preparation Products

BTO-1 Suppliers

Global( 20)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Aladdin Scientific +1-+1(833)-552-7181 United States 52927 58 Inquiry
Shanghai Aladdin Biochemical Technology Co.,Ltd. +86-18521732826 China 48465 58 Inquiry
TargetMol Chemicals Inc. 4008200310 China 24647 58 Inquiry
SIGMA-RBI 800 736 3690 (Orders) Switzerland 6913 91 Inquiry
Riedel-de Haen AG 800 558-9160 United States 6825 87 Inquiry
Sigma-Aldrich 021-61415566 800-8193336 China 51471 80 Inquiry
Shanghai Ziqi Biological Technology Co., Ltd. 400-811-9081 13681619662 CHINA 6192 58 Inquiry
Beijing Fubo Biotechnology Co., Ltd. 010-57263844 13260236521 CHINA 6039 58 Inquiry
Guangzhou Weijia Technology Co., Ltd. 020-84224925 18300190102 CHINA 6748 58 Inquiry
BTO-1 5-Cyano-7-nitro-2-benzothiazolecarboxamide-3-oxide Polo-like Kinase Inhibitor II, BTO-1 Polo-like Kinase Inhibitor II, BTO-1 - CAS 40647-02-7 - Calbiochem 2-Benzothiazolecarboxamide, 5-cyano-7-nitro-, 3-oxide 40647-02-7 C9H4N4O4S